New Clinical Trial on Hesperidin

February 16, 2021

A natural product to fight symptoms related to COVID-19

The Montreal Heart Institute (MHI) is launching a new clinical trial to evaluate the effect of hesperidin on symptoms related to COVID-19. This flavonoid naturally found in citrus fruits has distinct properties that may reduce the entry and replication of the SARS-CoV2 virus in the body along with the modulation of inflammatory mediators, thus potentially reducing symptoms and prevent complications from the disease.

Read more

Caregiver visits suspended at 3rd East and 3rd Center

January 29, 2021

Due to an outbreak in the surgical continuum, caregiver visits are suspended indefinitely.

Caregivers will not be able to come to the surgical intensive care unit (3rd east) and the surgical unit (3rd center) until further notice.

In exceptional situations or for humanitarian reasons (eg: end of life), a caregiver may be authorized, with the agreement of the care unit.

Read more

Major scientific breakthrough to treat COVID-19

January 27, 2021

UPDATE: COLCORONA study manuscript is now available in the public domain.


On January 22, 2021, the Montreal Heart Institute announced positive results from COLCORONA trial. These results showed that colchicine is the only effective oral medication for treating non-hospitalized patients.

Read more